LOS ANGELES — ​ASHG Annual Meeting –Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq). The new cloud analysis platform will provide an accessible option for researchers to analyze scRNA-seq data without required bioinformatics […]

DALLAS — Catalyze Dallas Holdings today announces the launch of another portfolio company, Almaden Genomics, which is accelerating genomic research and discovery through streamlined bioinformatics. Almaden is the latest in a series of commercialization efforts by Catalyze to speed go-to-market for technology harvested from the Fortune 100. “The global genomics market is expected to reach nearly $129 billion […]

EMERYVILLE, Calif. and HORSENS, Denmark — Abalone Bio, a preclinical biotherapeutics company and PipeBio, a bioinformatics cloud platform provider, announce their continued collaboration around antibody bioinformatics analysis supporting Abalone Bio’s antibody discovery research and development efforts. PipeBio’s advanced bioinformatic platform complements Abalone Bio’s Functional Antibody Selection Technology (FAST) antibody discovery platform, which aims to find treatments […]

DALLAS – Almaden Genomics has launched g.nome™, a cloud-native platform designed to streamline genomic workflows and accelerate genomic discovery. Leveraging an advanced visual drag-and-drop workflow builder and curated library of toolkits, g.nome enables users to have confidence in their results, get to market faster and scale their business profitably. Brought to market by a team of […]

Abu Dhabi: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions. The collaboration is a pivotal step in G42 Healthcare’s strategy to support the health […]

Industry veteran brings longstanding track record of growing innovative healthcare technology and service organizations from early-stage startup through category leadership MOUNTAIN VIEW, Calif. –(BUSINESS WIRE)–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of Jeff Margolis, a seasoned healthcare information technology executive and current Senior Advisor for Blackstone (NYSE:BX), to […]

Deeptech | Personalized Genomic Medicine I A.I. Renowned specialist in healthcare data science, he will focus on developing A.I. driven genomic analysis solutions to facilitate personalised medicine in oncology and rare diseases MONTPELLIER, France–(BUSINESS WIRE)– SeqOne Genomics, today announced that Michael Blum, Ph.D. is joining the company to lead its research and development department. He is […]

Latest enterprise software release expands functionalities for comprehensive characterization and quality monitoring of biopharmaceuticals Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist® 16.5, the latest version of its platform for streamlining and automating mass spectrometry data workflows, from early discovery to late-stage […]

Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership with P4 Diagnostix®, a leading-edge network of nationally recognized laboratories. Now physician-owned laboratories (POLs) that specialize in urology, gastroenterology, or women’s health, can add next-generation sequencing (NGS) testing for hereditary cancer to their routine diagnostic practice. Lowering the […]

– Qlucore’s software is used in leading research projects Swedish Qlucore – a leader in precision diagnostics for the analysis of cancer – has played an important role in the Swedish-Danish collaboration iCOPE, which aims, among other things, to improve the treatment of children affected by acute leukemia. With diagnoses increasing by 6-10 percent a […]